Navigation Links
Quest Diagnostics and Genomic Vision Form Strategic Collaboration to Develop Genome-based Laboratory Tests
Date:7/14/2011

160;current DNA analytical technologies cannot detect.

"Quest Diagnostics has a superb track record of turning cutting-edge genetic research and techniques into clinically validated diagnostics," said Founder, CEO and molecular combing inventor Dr. Aaron Bensimon. "Our collaboration with Quest Diagnostics puts molecular combing on track to fulfill its potential to help improve disease detection and new drug development for patients worldwide."

"Quest Diagnostics has a unique ability to collaborate with innovative companies like Genomic Vision to develop advanced genetic tests that serve unmet patient needs," said Kathy P. Ordonez, senior vice president, discovery and development, Quest Diagnostics. "We look forward to incorporating Genomic Vision's unique DNA combing technology into new diagnostic tests that can help identify the genetic causes of disease missed by other techniques." 

Quest Diagnostics expects to validate and release the first laboratory developed test based on molecular combing, for aiding the detection of individuals affected with facioscapulohumeral muscular dystrophy, in 2012. The companies will also focus on developing tests for cancer and neurological disorders, with testing services to be offered to clients of Quest Diagnostics. Quest Diagnostics may also offer molecular combing-based laboratory testing services for new drug development to pharmaceutical companies through its clinical trials business and for research use to academic institutions, beginning in 2012.

About Genomic Vision

Genomic Vision is a Paris-based biotechnology company which develops and commercializes novel diagnostic tests in the field of cancer and genetic diseases. Backed by blue-chip venture capital investors Amundi Private Equity Funds and Vesalius Biocapital, the Company holds an exclusive license from the Pasteur Institute for the exploitation of Molecular Combing - a technolog
'/>"/>

SOURCE Quest Diagnostics
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Clinical Genomics Extends Strategic Alliance for Colorectal Cancer Testing Development with Quest Diagnostics
2. GEN point of view article questions reported costs of drug R&D
3. Questcor Pharmaceuticals to Present at the Jefferies Global Healthcare Conference on June 9, 2011
4. FDA Requests Input on Development of User Fee Program for Biosimilar and Interchangeable Biological Products
5. GenomeQuest to Lead Biomarker World Congress Panel on Applying Whole Genome Sequencing to Developing Companion Diagnostics
6. New York State Approves the Quest Diagnostics ColoVantage™ Colorectal Cancer Blood Test
7. After the ABRF Conference: Gene Codes Flooded with Requests for Early Access to NextGen Software Tools
8. MDAs Augies Quest Expands Testing of Potential ALS Therapeutics With New $2 Million Grant to ALS TDI
9. Quest Diagnostics to Acquire Athena Diagnostics, Establishing Leading Position in Rapidly Growing Neurology Testing Market
10. Questcor Pharmaceuticals to Be Added to S&P SmallCap 600 Index
11. Quest Diagnostics® Care360™ EHR Receives ONC-ATCB 2011/2012 Certification
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/16/2015)... April 16, 2015 Cytokinetics, Incorporated (Nasdaq: ... first quarter results on Thursday, April 30, 2015 at ... management will host a conference call at 4:30 PM ... the company’s outlook for the future. , The conference ... from the homepage and in the Investor Relations section ...
(Date:4/16/2015)... Proove Biosciences , Inc. is ... Contest for the 2015 BIO International Convention. Hosted ... International Convention will take place June 15-18 at the ... of BIO contest, industry leaders will be voting for ... conference. The community voting period began on April 14, ...
(Date:4/16/2015)... (PRWEB) April 16, 2015 Regis Technologies ... American Association for Cancer Research (AACR) annual meeting. Regis ... Convention Center, starting Saturday, April 18, in Philadelphia and ... claim to title of the oldest and largest organization ... fellowships and grants, and partners with survivors to promote ...
(Date:4/16/2015)... (PRWEB) April 16, 2015 ... at Charlotte (UNC Charlotte) spin-out company, announced today ... Cooper, Ph.D., M.D., as Chief Operating Officer (COO). ... of experience in developing clinical diagnostic and biotechnology ... infectious disease. , Cooper’s extensive career transcends the ...
Breaking Biology Technology:Cytokinetics to Announce First Quarter Results on April 30, 2015 2Cytokinetics to Announce First Quarter Results on April 30, 2015 3Proove Bisociences to Participate in the Buzz of BIO at the 2015 BIO International Convention 2Proove Bisociences to Participate in the Buzz of BIO at the 2015 BIO International Convention 3Regis Technologies Joins American Association for Cancer Research Annual Meeting 2OncoTAb Names Dr. David L. Cooper as COO 2
... LAKES, N.J., June 1 BD (Becton, Dickinson and Company) (NYSE: BDX ), ... healthcare conferences in June: , , Goldman Sachs ... 11:40 a.m. EDT, ... June 11, 2009, 10:00 a.m. EDT, , ...
... ARBOR, Mich., June 1 Assay Designs, Inc., a ... the life science and translational research markets, has announced ... dedicated to the analysis of heat shock proteins and ... , The bead-based multiplex immunoassay enables measurement of ...
... Pharmaceuticals Corp. ("Raptor" or the "Company") (OTC Bulletin ... the first patient in its Phase 2b clinical ... of California, San Diego ("UCSD"), to evaluate ... in nephropathic cystinosis ("cystinosis"), a rare genetic lysosomal ...
Cached Biology Technology:Assay Designs(TM), Inc. Announces Release of First Available Product for Multiplex Analysis of Heat Shock Proteins 2Raptor Pharmaceuticals Doses First Patient in Phase 2b Clinical Trial of DR Cysteamine for Cystinosis 2Raptor Pharmaceuticals Doses First Patient in Phase 2b Clinical Trial of DR Cysteamine for Cystinosis 3Raptor Pharmaceuticals Doses First Patient in Phase 2b Clinical Trial of DR Cysteamine for Cystinosis 4Raptor Pharmaceuticals Doses First Patient in Phase 2b Clinical Trial of DR Cysteamine for Cystinosis 5
(Date:4/10/2015)... 10, 2015 Research and Markets ... "Security Competitive Profiles - NEC" report to ... NEC will continue to supply a range of ... with a company focus on the development of a ... Winning opportunities in the Asia-Pacific ...
(Date:4/2/2015)... 2, 2015 In the ... far outperforms the strongest competitors, showing outstanding performance ... the system is capable of a throughput of ... up to be ten times faster than most ... performance.      (Photo: http://photos.prnewswire.com/prnh/20150402/738673-a ...
(Date:4/1/2015)... -- NXT-ID, Inc. (NASDAQ: NXTD ) ("NXT-ID" or the ... mobile commerce market, announces the second shipment of a ... early access pre-order customers. Feedback from ... including Walmart, Target, AT&T, Dunkin, Donuts, Stop & Shop ... all outlets and very easy to use. Several users ...
Breaking Biology News(10 mins):NEC Security Competitive Profile 2015 2DERMALOG AFIS Emerges as Performance Winner in NIST Benchmark Test 2DERMALOG AFIS Emerges as Performance Winner in NIST Benchmark Test 3NXT-ID Reports Second Shipment of Wocket Smart Wallets Underway to Early Access Pre-order Customers and Provides User Feedback 2NXT-ID Reports Second Shipment of Wocket Smart Wallets Underway to Early Access Pre-order Customers and Provides User Feedback 3NXT-ID Reports Second Shipment of Wocket Smart Wallets Underway to Early Access Pre-order Customers and Provides User Feedback 4
... Medicine uses PET, radiotracer to track enzyme in smokers, ... in the lungs, possibly contributing to some of smoking's ... the September issue of the Journal of Nuclear Medicine. ... enzyme, also shows that smokers had a lower concentration ...
... of Pennsylvania School of Medicine found that a protein ... development of hematopoietic stem cells (HSC), or blood-producing stem ... pathway may one day lead to new treatments for ... better understanding of how HSCs work in the context ...
... A new study of 60 beaches in Southern California ... reaching the highest levels when tides are ebbing during ... beachgoers and managers better assess the potential risk of ... issue of the American Chemical Society's journal Environmental Science ...
Cached Biology News:Smoking damages key regulatory enzyme in the lung 2Smoking damages key regulatory enzyme in the lung 3Master regulatory gene found that guides fate of blood-producing stem cells 2Beach pollution is worst during new and full moon 2
Originally developed for the culture of Drosophila; suitable for culture of other dipteran cell lines. Powder, Insect cell culture tested...
... number is a new product ... Cornings product number. If showing ... under the old Sigma-Aldrich number ... for assistance. Mfr Desig: ...
... polystyrene with frosted labeling surfaces, volume ... counting. 100% integrity tested. Linkage: This ... number, created to easily match Cornings ... yet, please order under the old ...
... ® Ek Adaptor encodes a T7 ... site (rbs), ATG translation initation codon, and ... is a small epitope tag (11 aa) ... target protein with T7•Tag Monoclonal Antibody and ...
Biology Products: